01 1Intas Pharmaceuticals
01 1RIBOCICLIB SUCCINATE
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2021-11-18
Pay. Date : 2021-09-24
DMF Number : 36335
Submission : 2021-09-30
Status : Active
Type : II
20
Intas Pharmaceuticals Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is RIBOCICLIB SUCCINATE, with a corresponding US DMF Number 36335.
Remarkably, this DMF maintains an Active status since its submission on September 30, 2021, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 18, 2021, and payment made on September 24, 2021, indicating their dedication to facilitating drug approvals, Categorized as Type II
